Eliot L Gardner Selected Research

Eliot L Gardner Research Topics

Disease

21	Cocaine-Related Disorders (Cocaine Addiction) 08/2017 - 11/2002
10	Substance-Related Disorders (Drug Abuse) 12/2018 - 07/2005
7	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 12/2010
3	Tobacco Use Disorder (Nicotine Dependence) 12/2019 - 06/2009
2	Catalepsy 01/2020 - 06/2005
2	Obesity 03/2019 - 06/2008
2	Mental Disorders (Mental Disorder) 03/2015 - 03/2008
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Motor Disorders 01/2021
1	Cognitive Dysfunction 07/2020
1	Hypothermia 01/2020
1	Hyperalgesia 12/2019
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 12/2018
1	Heroin Dependence (Heroin Abuse) 12/2018
1	Alcoholism (Alcohol Abuse) 11/2018
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018
1	Pain (Aches) 12/2017
1	Inflammation (Inflammations) 11/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2016
1	Binge Drinking 06/2015
1	Sleep Wake Disorders 06/2015
1	Morphine Dependence 01/2012
1	Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic) 06/2009
1	Neuralgia (Stump Neuralgia) 10/2008
1	Seizures (Absence Seizure) 10/2008
1	Shock 10/2004

Drug/Important Bio-Agent (IBA)

13	Cocaine (Cocaine HCl)IBA 12/2017 - 11/2002
10	Dopamine (Intropin)FDA LinkGeneric 12/2018 - 01/2004
9	Dopamine D3 ReceptorsIBA 01/2019 - 11/2002
8	Pharmaceutical PreparationsIBA 01/2022 - 12/2002
5	Opioid Analgesics (Opioids)IBA 01/2021 - 11/2017
3	CannabinoidsIBA 01/2021 - 11/2018
3	metabotropic glutamate receptor 7IBA 09/2010 - 03/2008
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022 - 11/2017
2	CB2 Cannabinoid ReceptorIBA 01/2021 - 01/2020
2	Nicotine FDA Link 12/2019 - 06/2009
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2018 - 01/2010
2	Naloxone (Narcan)FDA LinkGeneric 12/2018 - 01/2012
2	metabotropic glutamate receptor 2IBA 12/2018 - 01/2010
2	LigandsIBA 11/2018 - 11/2017
2	Modafinil (Provigil)FDA Link 08/2017 - 06/2015
2	NGB 2904IBA 01/2007 - 07/2006
1	GhrelinIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 07/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	XLR-11IBA 01/2020
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2020
1	RimonabantIBA 03/2019
1	AM4113IBA 03/2019
1	VK4-116IBA 01/2019
1	Heroin (Diamorphine)IBA 12/2018
1	Morphine (MS Contin)FDA LinkGeneric 12/2018
1	Oleic Acid (Oleate)IBA 11/2018
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2018
1	BAK4-54IBA 11/2017
1	CAB2-015IBA 11/2017
1	N- (2- ((bis(4- fluorophenyl)methyl)thio)ethyl)- 3- phenylpropan- 1- amineIBA 08/2017
1	Opiate AlkaloidsIBA 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2016
1	CannabidiolIBA 11/2016
1	Ethanol (Ethyl Alcohol)IBA 06/2015
1	SB 277011IBA 06/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 03/2015
1	YQA14IBA 02/2014
1	Sulfates (Sulfates, Inorganic)IBA 09/2013
1	fenobamIBA 09/2013
1	AMPA Receptors (AMPA Receptor)IBA 02/2012
1	GYKI 52466IBA 02/2012
1	Methadone (Dolophine)FDA LinkGeneric 12/2010
1	Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA 02/2010
1	gamma-Aminobutyric Acid (GABA)IBA 06/2009
1	N,N'-dibenzhydrylethane-1,2-diamine dihydrochlorideIBA 06/2009
1	N- (4- (2- (8- cyano- 1,3a,4,9b- tetrahydro(1)benzopyrano(3,4- c)pyrrol- 2(3H)- yl)ethyl)phenyl)acetamideIBA 03/2009
1	Gabapentin (Neurontin)FDA LinkGeneric 10/2008
1	Haloperidol (Haldol)FDA LinkGeneric 06/2005
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2004

Therapy/Procedure

10	Self Administration (Administration, Self) 07/2020 - 07/2006
4	Therapeutics 11/2018 - 10/2006
3	Analgesia 01/2021 - 12/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 11/2002
1	Oral Administration 11/2016